Mesoblast Limited
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-76.8M | $-4.1M |
| Depreciation & Amortization | — | — |
| Depreciation | $1.6M | $1.6M |
| Amortization | $1.5M | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $-95.5M | $-88.0M |
| Investing Activities | ||
| Capital Expenditures | — | — |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $142.0K | $-1.7M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $60.0M | $62.1M |
| Net Change in Cash | — | — |
| Free Cash Flow | — | — |